top of page

Since 1986, Madrid's PharmaMar has been searching the world's oceans for new cancer medicines - it has already led to three approved drugs

  • blonca9
  • Sep 17, 2024
  • 1 min read

Managing Director Luis Mora walks us through the company's development process, from divers in the ocean, to sample testing, and ultimately clinical trials. He also describes the significant investments in R&D the company has made.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

evaluate-logo-png_seeklogo-457165-2_edited.png

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

bottom of page